Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs Testosterone in Hypogonadal Men with T2D
NCT06489457Phase 3Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2020
- Primary completion
- May 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in functional hypogonadism (FHH), sponsored by University Medical Centre Ljubljana. Started Sep 2020; status: completed.
02
Drugs
03
Conditions
functional hypogonadism (FHH)
Beyond the preview
Go deeper on NCT06489457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06489457.